Provided by Tiger Fintech (Singapore) Pte. Ltd.

ADMA Biologics

20.81
-0.7900-3.66%
Post-market: 20.80-0.0100-0.05%19:21 EDT
Volume:2.77M
Turnover:57.67M
Market Cap:4.97B
PE:24.90
High:21.53
Open:21.25
Low:20.52
Close:21.60
Loading ...

Director Jerrold B. Grossman Reports Disposal of Common Shares in ADMA Biologics Inc

Reuters
·
11 Jun

ADMA Biologics Inc. Conducted Annual Stockholders Meeting

Reuters
·
05 Jun

ADMA Biologics Inc. Director Lawrence P. Guiheen Reports Disposal of Common Shares

Reuters
·
24 May

ADMA Biologics Inc. CEO Adam S. Grossman Reports Disposal of Common Shares

Reuters
·
17 May

ADMA Biologics Is Maintained at Strong Buy by Raymond James

Dow Jones
·
09 May

ADMA Biologics Inc : Raymond James Raises Target Price to $32 From $25

THOMSON REUTERS
·
08 May

ADMA Biologics Inc : Mizuho Raises Target Price to $35 From $32

THOMSON REUTERS
·
08 May

Stock Track | ADMA Biologics Plunges 5.80% After Q1 Earnings Miss Despite Raised Guidance and Buyback Plan

Stock Track
·
08 May

ADMA Biologics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

ADMA Biologics Q1 Earnings, Revenue Rise; Shares Fall After Hours

MT Newswires Live
·
08 May

Stock Track | ADMA Biologics Plunges 5.55% After-Hours on Q1 Earnings Miss Despite Growth and Share Buyback Announcement

Stock Track
·
08 May

ADMA Biologics Q1 Adj. EPS $0.14 Misses $0.16 Estimate, Sales $114.80M Miss $116.40M Estimate

Benzinga
·
08 May

BRIEF-ADMA Biologics Q1 Revenue USD 114.8 Million

Reuters
·
08 May

ADMA Biologics Q1 Gross Profit USD 61.1 Million

THOMSON REUTERS
·
08 May

ADMA Biologics Inc - Authorizes $500 Million Share Repurchase Program

THOMSON REUTERS
·
08 May

ADMA Biologics Inc - Total Annual Revenues Expected to Exceed $1.1 Billion by 2030

THOMSON REUTERS
·
08 May

ADMA Biologics Inc - FY 2025 & 2026 Revenue Guidance Increased to Over $500 Mln & $625 Mln, Respectively

THOMSON REUTERS
·
08 May

Adma Biologics options imply 10.9% move in share price post-earnings

TIPRANKS
·
08 May

Adma Biologics (ADMA) Increases Yet Falls Behind Market: What Investors Need to Know

Zacks
·
03 May

Has ADMA Biologics (ADMA) Outpaced Other Medical Stocks This Year?

Zacks
·
01 May